Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Measles Resurgence: Clinical Recognition, Public Health Response, and the Importance of Vaccination
Description
The talk reviews measles resurgence and what clinicians, especially dermatologists, should know to recognize and respond to it. The speaker explains that measles was declared eliminated in the U.S. in 2000 after widespread vaccination dramatically reduced cases, but sporadic imported outbreaks continued and recent years have seen a sharp rise again, driven by vaccine hesitancy, misinformation about vaccine safety and autism, and pandemic-related missed childhood vaccines. She emphasizes that measles remains highly contagious worldwide, with a very high R-naught, and that outbreaks can spread rapidly in under-immunized communities. Clinically, measles is a systemic viral illness marked by fever, cough, coryza, conjunctivitis, Koplik spots, and a morbilliform rash that begins on the face and spreads downward; complications include pneumonia, encephalitis, deafness, blindness, hospitalization, and death. Diagnosis should be suspected based on the classic clinical pattern and immediately reported to public health, with RT-PCR and serology used for confirmation. There is no definitive antiviral treatment, so management is supportive, includes airborne precautions, and may include vitamin A to reduce eye complications. Prevention is the key: the MMR vaccine is highly effective, recommended in a two-dose schedule, and post-exposure prophylaxis is available for eligible contacts. The speaker closes by urging clinicians to keep measles on their differential and to counsel patients strongly in favor of vaccination, noting that current vaccination rates are below the level needed for herd immunity.
View moreConclusions
- Measles has returned as a real clinical and public health threat, so clinicians should actively consider it in any compatible febrile rash illness.
- The dramatic decline in measles after vaccination shows that elimination was achieved through strong vaccination programs, coordinated public health, and favorable virology, not because the disease disappeared worldwide.
- Rising vaccine hesitancy and pandemic-related drops in routine childhood immunization have lowered MMR coverage below herd-immunity levels in many places.
- Because measles is extraordinarily contagious, even small immunity gaps can fuel large outbreaks and rapid spread through communities, schools, travel settings, and healthcare facilities.
- Prompt recognition, immediate public health reporting, and confirmatory testing are essential to prevent onward transmission when measles is suspected.
- Measles is a systemic illness with potentially serious complications, including pneumonia, blindness, encephalitis, deafness, and death.
- Measles can also suppress the immune system and erase prior immune memory, increasing vulnerability to other infections after recovery.
- There is no specific antiviral cure, so treatment is mainly supportive, with vitamin A used to reduce eye complications and airborne isolation to limit spread.
- The MMR vaccine is highly effective and generally safe, and its benefits far outweigh its uncommon adverse effects.
- The core strategy to control measles remains prevention through high vaccination uptake, especially rapid catch-up vaccination after missed doses or exposures.
- Paules CI, Marston HD, Fauci AS. Measles in 2019 — Going Backward. N Engl J Med. 2019 Jun 6.#10.1056/nejmp1905099
- Chat VS, Ellebrecht CT, Kingston P, et al. JAAD 2024;90;P1170-1181.
- MMWR Morb Mortal Wkly Rep. 2023 Nov 17; 72(46): 1262–1268.
- Measles outbreak among members of a religious community — Brooklyn, New York, March–June 2013. MMWR.
- Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.#10.1016/s0140-6736(10)60175-4